Effects of polysaccharides (AP) treatment (given subcutaneously once daily) on white blood cell (WBC) number in cyclophosphamide (CY)-treated mice

<p><b>Copyright information:</b></p><p>Taken from "Polysaccharides from the root of protect bone marrow and gastrointestinal tissues against the cytotoxicity of cyclophosphamide in mice"</p><p>International Journal of Medical Sciences 2006;3(1):1-6.</p><p>Published online 1 Jan 2006</p><p>PMCID:PMC1332197.</p><p>© Ivyspring International Publisher. This is an open access article. Reproduction is permitted for personal and noncommerical use, provided that the article is in whole, unmodified, and properly cited.</p> CY was given subcutaneously (200 mg/kg) at day 0 and day 7 and AP was also injected subcutaneously once daily during the 14-day experimental period. Nor: Normal untreated group; NS: normal saline plus CY-treated group; AP5: AP 5 mg/kg plus CY-treated group, AP10: AP 10 mg/kg plus CY-treated group, AP25: AP 25 mg/kg plus CY-treated group, respectively.

Effects of polysaccharides (AP) treatment (given subcutaneously once daily) on the blood vessel count in (A) gastric and (B) intestinal mucosae in cyclophosphamide (CY given subcutaneously 200 mg/kg)-treated mice

<p><b>Copyright information:</b></p><p>Taken from "Polysaccharides from the root of protect bone marrow and gastrointestinal tissues against the cytotoxicity of cyclophosphamide in mice"</p><p>International Journal of Medical Sciences 2006;3(1):1-6.</p><p>Published online 1 Jan 2006</p><p>PMCID:PMC1332197.</p><p>© Ivyspring International Publisher. This is an open access article. Reproduction is permitted for personal and noncommerical use, provided that the article is in whole, unmodified, and properly cited.</p> Nor: Normal untreated group. NS: normal saline plus CY-treated group. AP5: AP 5 mg/kg plus CY-treated group, AP10: AP 10 mg/kg plus CY-treated group, AP25: AP 25 mg/kg plus CY-treated group, respectively. *P< 0.05, compared to Nor. P< 0.05 compared to the N